Emcure Pharmaceuticals reported a 38.2% YoY rise in Q2FY25 net profit to Rs 202 crore, driven by strong domestic and international sales. Revenues grew 20.4% to Rs 2,002 crore, while EBITDA rose 26%, with margins at 20.8%.
| Subscribe To Our Free Newsletter |
